TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CLEO Diagnostics Ltd ( (AU:COV) ) just unveiled an announcement.
Cleo Diagnostics Limited reported a 12.8% decrease in revenues to $339,590 for the year ending June 30, 2025, alongside a 6.4% increase in losses, totaling $3,999,134. The company did not declare any dividends for the period, and the net tangible assets per ordinary security decreased from 6.99 cents to 4.26 cents, indicating financial challenges and potential implications for stakeholders.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Limited operates in the healthcare industry, focusing on diagnostic services and products. The company is involved in developing and providing diagnostic solutions, although specific market focus details are not provided.
Average Trading Volume: 68,152
Technical Sentiment Signal: Hold
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.